Cai et al. [11] demonstrated convincingly that EZH2 is a highly sensitive diagnostic biomarker of HCC, which can be used to distinguish it from benign liver lesions such as hepatocellular adenomas, focal nodular hyperplasias, dysplastic and regenerative nodules. The gene discussed is EZH2; the disease is hepatocellular carcinoma.